XML 57 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Income Statement [Abstract]    
Revenues $ 0 $ 0
Cost of revenues 0 0
Gross margin 0 0
Operating expenses    
General and administrative 611,845 624,674
Warrants, options and stock compensation 149,885 1,316,148
Legal and professional services 131,686 143,103
Depreciation and amortization 478,104 8,687
Total operating expenses 1,371,520 2,092,612
Loss from operations (1,371,520) (2,092,612)
Other (income)/expenses    
Loss on adjustments to fair value of derivative liability 0 236,850
Other income (49,639) (2,564)
Interest expense 58,294 22,971
Total other expenses 8,655 257,257
Net loss from continuing operations (1,380,175) (2,349,869)
Net loss from discontinued operations 0 (126,911)
Net loss (1,380,175) (2,476,780)
Preferred dividends $ 0 $ 124,375
Net loss attributable to holders of RestorGenex Corporation common stock $ (1,380,175) $ (2,601,155)
Basic and diluted loss per share for continuing operations $ (0.23) $ (2.77)
Basic and diluted loss per share for discontinued operations $ 0 $ (0.14)
Total basic and diluted loss per share $ (0.23) $ (2.91)
Basic weighted average shares outstanding 5,934,474 892,534
Fully-diluted weighted average shares outstanding 5,934,474 1,207,534